- 1 What is the potential benefit?
- 2 Who is a suitable candidates?
- 3 Who is an unsuitable candidate?
- 4 What skin, soft tissue, and musculoskeletal tissues can be treated?
- 5 What are the risks?
- 6 What is the cost of treatment at MRM?
- 7 At which locations is the treatment performed?
- 8 What if I am a suitable candidate for treatment?
- 9 Where do the stem cells come from?
- 10 What is the success rate?
- 11 Does treatment consist of one or multiple injections?
- 12 Free Consultation
What is the potential benefit?
Stem cell treatments containing SVF with cell populations of regenerative cells, including mesenchymal stem cells, stromal cells, progenitor cells, endothelial cells, lymphocytes, macrophages, and pericytes, provide a non-surgical treatment option to reduce pain and to promote natural healing and tissue regeneration, while still providing long-lasting relief, or potentially a cure, from a chronic degenerative skin or soft tissue or musculoskeletal condition.
Who is a suitable candidates?
In general, stem cell treatments can be appropriate for patients suffering from a degenerative skin, soft tissue, or musculoskeletal condition. This includes mild to moderate osteoarthritis affecting body areas such as the knee, shoulder, hip, ankle, foot, hand, or digits. Stem cell treatments can also be appropriate for patients with skin and soft tissue conditions such as wounds, scars, chronic tendinitis, partially torn tendons, and damaged musculoskeletal tissues, including damage or degeneration of the rotator cuff, labrum, meniscus, or avascular necrosis of bone.
Who is an unsuitable candidate?
Conditions excluding a patient from being a suitable candidate for a stem cell treatment at MRM include:
- a patient with active cancer not in remission for at least 5 years; or prior lymphoma, leukemia
- a patient with a current or active infection
- a patient needing to take blood thinners (such as Coumadin or Warfarin)
- a patient needing to take anti-platelet medications (such as to prevent stroke or stenosis of coronary stent)
- a patient with a contraindication to having bone marrow harvested, or fat harvested by liposuction, or whole blood collected by venipuncture
- a patient with complex or severe medical issues
- an elderly patient, perhaps beyond age 75 (since the number and regenerative capability of stem cells decreases with advancing age)
What skin, soft tissue, and musculoskeletal tissues can be treated?
The most common degenerative conditions treated with stem cells, SVF, and HD-PRP include the scalp for biocellular hair restoration, the face for skin regeneration and fat volume replacement, scars and wounds for skin and soft tissue regeneration, and the knee, shoulder, hip, ankle, hand, digits, and tendons for musculoskeletal tissue regeneration.
What are the risks?
A stem cell (SVF) treatment to treat a degenerative condition uses your own bone marrow or fat tissue, which contains stem cells and SVF. Since the stem cells come from your own body, there is no chance of rejection or allergic reaction to these biocellular agents. There is a small risk of infection following a stem cell treatment, however prophylactic antibiotics and sterilizing skin preparations are routinely used at MRM for all stem cell, SVF, and HD-PRP treatments. You can expect some soreness at the tissue harvest site and the stem cell (SVF) recipient injection site for a few days following the procedure.
What is the cost of treatment at MRM?
The price for a stem cell treatment at MRM that involves injection of stem cells, SVF, and HD-PRP inclusive of precision image guidance with fluoroscopy and/or ultrasonagraphy is $5900. The number of degenerative areas that can be treated during a single stem cell (SVF) treatment session will vary, depending on the dimensions of the recipient site(s).
Treatments with stem cells, SVF and HD-PRP are not a covered benefit of Medicare or private insurance. Payment is due and payable to Minnesota Regenerative Medicine prior to treatment.
At which locations is the treatment performed?
Our regenerative medicine specialists at Minnesota Regenerative Medicine currently provide stem cell, SVF, and HD-PRP treatments only at our Maple Grove facility. A complete stem cell treatment session usually takes several hours to perform.
What if I am a suitable candidate for treatment?
If you can make the trip, we recommend that you schedule an appointment for a regenerative medicine consultation to determine if you are a suitable candidate for a stem cell, SVF, and HD-PRP treatment. To expedite this process, we ask that you bring with you a copy of any MRI, X-ray, imaging, or radiology typed reports for our specialists to read, as well as any other pertinent medical records.
Where do the stem cells come from?
The stem cells and SVF used for a stem cell treatment originate from the patient’s own bone marrow or fat tissue, where surplus stem cells reside throughout the tissue within its stromal vascular fraction.
What is the success rate?
Since we began performing stem cell and SVF treatments in 2011, our experience is that most patients experience varying degrees of pain relief and various levels of functional improvement following treatment for a degenerative condition. It is rare for a patient not to experience some degree of pain relief or functional improvement or signs of tissue healing following a stem cell, SVF, and HD-PRP treatment at MRM.
Sometimes, for large joints such as shoulders and knees, we recommend high-density platelet-rich plasma (HD-PRP) injections be performed monthly for 2 consecutive months following the initial stem cell, SVF, and HD-PRP treatment in order to maximize treatment results, since PRP’s myriad of growth factors and bioactive agents stimulate neighboring stem cells to continue to divide and differentiate. Each HD-PRP treatment beyond the initial stem cell, SVF, HD-PRP treatment session will incur an additional charge. Ongoing clinical improvement following a stem cell, SVF, HD-PRP treatment can continue for a year or two. Of the many patients treated so far at MRM, the majority of patients asked during their follow-up visits have self-reported significant pain relief, functional improvement, or signs of tissue healing following stem cell, SVF, and HD-PRP treatment.
Does treatment consist of one or multiple injections?
The number of injections per treatment session varies, depending on the size, severity and complexity of the degenerative condition being treated. The needles used at MRM are 25-Gauge or smaller in diameter, since the solution containing either the stem cells, SVF, or HD-PRP is close to the consistency of water. This is in contrast to the large needles required to inject thick, viscous solutions such as corticosteroids or visco-supplements (hyaluronic acid).
Our regenerative medicine specialist consults with each patient to customize a regenerative medicine treatment plan specific to their degenerative condition.